Viewing nowPosilozin 10 mg (Dapagliflozin Monohydrate Mixture)
Dapagliflozin Anhydrous Lactose Mixture 15.27mg
Tablet · Prescription medication
Hanwha Pharmaceutical Co., Ltd.

MFDS item code 202005363 · Approved 2020.07.23 · Insurance code 651602770
Improvement of glycemic control in type 2 diabetes mellitus
This drug helps effectively control blood sugar levels in patients with type 2 diabetes. It should be used as an adjunct to dietary and exercise therapy, and can be administered alone or in combination with other medications. Particularly, patients with cardiovascular diseases or risk factors should consult with specialists regarding blood sugar management and prevention of cardiovascular events. This drug improves blood sugar control and contributes to the prevention of complications.
Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this medicine is 10 mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, such as insulin. When this medicine is used in combination with insulin or an insulin secretagogue such as a sulfonylurea, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients who have not previously received diabetes medication, the recommended initial dose of this medicine when administered in combination with metformin is 5 mg once daily or 10 mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Use of this medicine to improve glycemic control is not recommended. - Patients on dialysis: Do not administer this medicine. Hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, 5 mg is recommended as the starting dose. If well tolerated, this dose may be increased to 10mg. Elderly (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This medicine may be taken orally once daily at any time of day, with or without food. The tablet should be swallowed whole.
The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.
This drug should not be administered to certain patients. For example, patients allergic to this drug's ingredients or additives, patients with type 1 diabetes, diabetic ketoacidosis patients, patients with genetic issues such as lactose intolerance, and patients undergoing dialysis should not use this drug. Caution should be exercised when administering this drug to patients with volume depletion or impaired kidney function. This drug may lower blood pressure or affect kidney function, thus patients with impaired kidney function, the elderly, and those taking diuretics should be carefully monitored regarding their fluid status and kidney function. This drug contains yellow pigments (Yellow No. 4, Yellow No. 5), so patients with allergic reactions to these ingredients should be cautious. Common side effects while taking this drug can include genital infections, urinary tract infections, hypoglycemia, volume depletion, dizziness, and dry mouth. In particular, genital infections may occur more frequently in women, so appropriate treatment is necessary if symptoms appear. Due to the risk of diabetic ketoacidosis, symptoms such as nausea, vomiting, abdominal pain, and shortness of breath should prompt an immediate visit to a hospital. Additionally, this drug may affect kidney function, so it is important for patients with impaired kidney function to regularly check their creatinine levels. While this drug helps control blood sugar, the risk of hypoglycemia may increase when used in combination with insulin or sulfonylureas, so dose adjustments for these medications may be necessary. It is safer for pregnant or breastfeeding women not to use this drug. In cases of overdose, since there is no specific antidote, it is important to receive appropriate treatment based on symptoms. Finally, this drug does not significantly affect driving or operating machinery, but caution is needed due to the risk of hypoglycemia. It is important to follow the doctor's advice for regular testing while taking this drug and to consult immediately if abnormal symptoms occur.
Not everyone experiences these, and they can vary from person to person.
This drug should be stored in a tightly closed container to protect it from air and moisture. Additionally, it is advisable to store the drug at room temperature between 1 degree and 30 degrees Celsius, rather than in very hot or very cold places. Proper storage can help maintain the drug's effectiveness for a longer time.
Yellow, double-convex rhombus-shaped film-coated tablets
28 tablets/box [14 tablets/PTP x 2]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowDapagliflozin Anhydrous Lactose Mixture 15.27mg
Tablet · Prescription medication
Hanwha Pharmaceutical Co., Ltd.
Dapagliflozin Anhydrous Lactose Mixture 7.635mg
Tablet · Prescription medication
International Pharmaceuticals Co., Ltd.

Dapagliflozin Anhydrous Lactose Mixture 15.27mg
Tablet · Prescription medication
International Pharmaceutical Co., Ltd.
Dapagliflozin Anhydrous Lactose Mixture 7.635mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Dapagliflozin Anhydrous Lactose Mixture 15.27mg
Tablet · Prescription medication
Sinil Pharmaceutical Co., Ltd.
Dapagliflozin Anhydrous Lactose Mixture 7.635mg
Tablet · Prescription medication
Dongwha Pharmaceutical Co., Ltd.

Dapagliflozin Anhydrous Lactose Mixture 15.27mg
Tablet · Prescription medication
Donghwa Pharmaceutical Co., Ltd.
Dapagliflozin Anhydrous Lactose Mixture 7.635mg
Tablet · Prescription medication
Albozen Korea Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.